What were Balchem Corp's record Q2 2026 consolidated sales and adjusted EBITDA, and how did they compare year-over-year?

Balchem Corp reported record consolidated sales of $284 million for Q2 2026, representing an 11.2% increase year-over-year, and record adjusted EBITDA of $78 million. The growth was broad-based across all segments, including significant gains in Animal Nutrition & Health and Specialty Products, while Human Nutrition & Health also achieved record sales. Despite higher input costs and operating expenses, the company delivered its 28th consecutive quarter of year-over-year growth in adjusted EBITDA and strengthened financial flexibility through a revolving credit facility refinancing.

How did Balchem Corp sustain profitability amid rising costs in Q2 2026?

Despite higher input costs and operating expenses, Balchem Corp sustained profitability in Q2 2026 by achieving record adjusted EBITDA of $78 million — its 28th consecutive quarter of year-over-year growth in that metric — supported by broad-based growth across all business segments, including significant gains in Animal Nutrition & Health and Specialty Products, and record sales in Human Nutrition & Health. The company also strengthened its financial flexibility through a revolving credit facility refinancing, underscoring disciplined capital management alongside operational execution.

ChemBrief

Topics Daily Digest Tags

Balchem Corp Reports Record Q2 2026 Sales and EBITDA

Aug 1, 2026

Balchem Corp reported record consolidated sales of $284 million and adjusted EBITDA of $78 million for Q2 2026, driven by growth in Animal and Human Nutrition segments despite higher input costs.

GuruFocus

2026-07-17

Balchem Corporation to announce Q2FY26 results on July 31

2026-07-23

Balchem Earnings Up Next: Can Specialty Ingredients Sustain Growth?

2026-07-27

Balchem (BCPC) Q2 2026 Preview: EPS Est. $1.43, Reports July 31

2026-07-31

Balchem Corporation Posts Q2 Adjusted EPS of $1.49, Surpassing Estimates

2026-07-31

Balchem Corporation Reports Second Quarter 2026 Financial Results